Injectable Drug Delivery Market Analysis By Type(Devices, Formulations), By Formulation Packaging(Ampules, Vials, Cartridges, Bottles), By Therapeutic Application(Auto-immune diseases, Hormonal Disorders, Orphan Diseases, Oncology), By Usage Pattern(Curative Care, Immunization), By Site of Administration(Skin, Circulatory/Musculoskeletal, Organs, Central Nervous System), By Distribution Channel(Hospitals & Clinics, Retail Pharmacy Stores), By Facility of Use(Hospitals & Clinics, Home Care Settings) & Forecast 2024-2035
- PUBLISHED ON
- 9/22/2022
- NO OF PAGES
- 231
- CATEGORY
- Healthcare & Life Sciences
The global injectable drug delivery market size was valued at USD 561.0 billion in 2021 and is projected to reach up to 1,223.0 million in 2030, with a CAGR of 9.0% in the forecasted period.
The rising prevalence of cancer, increasing incidences of chronic diseases are driving the market growth. Moreover, the rise in biologics market is also among the prominent factors for the market growth in the forecasted period.
One of the substantial factors driving the growth of global injectable drug delivery market is rising prevalence of cancer. As per the International Agency for Research on Cancer, 1 in 5 individuals will develop cancer during their lifetime by December 2020, with 1 in 8 men and 1 in 11 women dying from the disease globally. According to the International Agency for Research, cancer cases and deaths will grow up to 19.3 million cases and 10 million deaths in 2020, up from 18 million cases and deaths in 2018. Moreover, the major market players are concentrating on new product development and launches. For instance, the U.S. Food and Drug Administration approved Apretude for pre-exposure prophylaxis to lower the risk of sexually acquired HIV in adults weighing at least 35 kg in December 2021.
The COVID-19 pandemic has both valuable and negative impacts on the healthcare sector. The escalating COVID-19 patient populace is placing strain on healthcare systems. Due to the improved demand for medical things such as injections and pre-filled syringes, manufacturers have enhanced their making capacity to keep up with demand. Additionally, the government around the globe is backing towards the growth of injectable drugs delivery market. The government is profoundly investing for the growth and launch of novel injectable drugs delivery in the market.
Type Insights
The devices segment accounted largest revenue share in 2021. The growing prevalence of chronic disorders is leading to an increase in overall syringe practice, predominantly disposable syringes. The cardiovascular illnesses, diabetes, and obesity have been found to be leading causes of death from chronic disorders. As populace surge is believed to be the critical factor in emerging nations, this is likely to have the highest impact all around the world.
Therapeutic Application Insights
The auto-immune diseases segment hold the largest revenue share in 2021. The immune system bouts and terminates its own body tissue in autoimmune disorders. The diabetes, rheumatoid arthritis, lupus, and other auto-immune diseases are amongst the most frequent diseases. Anti-inflammatory medicines, immune suppressants, and other medicines have been approved to treat auto-immune diseases.
The oncology segment is fastest developing segment of the injectable drugs delivery market in 2021. The rising prevalence of cancer is fuelling the growth of the segment. As per the data of the American Cancer Society, by 2020, there will be around 1,806,590 cancer patients in the U.S. alone, up 31% from 2010.
Distribution Channel Insights
The hospitals segment holds the maximum share in the injectable drugs delivery market in 2021. This is attributed to an increase in the patient’s admitted to hospitals with acute and chronic wounds. Moreover, growth of the segment is also being compelled by the surge in the number of individual clinics in developed and emerging countries.
The retail pharmacy stores segment is predicted to show substantial growth over the forecasted period. The retail pharmacies trade pharmaceutical medications and drugs. These stores provide generic and branded medications, and other pharmaceutical supplies. The increasing preference of patients for purchasing injectable drugs delivery from these stores is boosting the growth of the segment.
Regional Insights
North America is expected to dominate the injectable drugs delivery market in 2021. The rise of injectable drugs delivery market in North America region is being accredited to the rising prevalence of numerous disorders. As per the Alzheimer’s Association, around 6.2 million Americans aged 65 and older will have Alzheimer’s disease by 2020. There are around 3.8 million women and 2.4 million men among those patients. Furthermore, increasing adoption of approaches by market players are also aiding the growth of North America injectable drugs delivery market. For instance, in July 2020, Piramal Critical Care collaborated with Medivant Healthcare, to answer the substantial shortage of injectable medications in hospitals across the nation.
Increased R&D investments, government initiatives to increase awareness about chronic diseases, and rise in healthcare spending are some of the factors that are driving the growth of the injectable drug delivery market in these regions.
Europe, is predicted to grow at the fastest rate during the forecasted period. The UK holds the largest share in the injectable drugs delivery market in Europe region. The Europe injectable drugs delivery market is attributed to the factors such as the rise of the biologics market, increasing incidence of chronic disorders, and the growing demand for self-injection devices are all contributing to this trend. The other factors impelling the growth of injectable drugs delivery market in Europe region are escalating disposable income, growing number of partnerships, and increasing awareness about safety and comfort.
However, a considerably large patient pool in the Asia Pacific region will provide probable growth openings for players in the injectable drug delivery market.
Key Companies Insights
Key players are aiming on their technological partnerships, collaborations, and merger & acquisitions strategies to gain an economical edge and grow their product portfolio & business footmarks. The Covid-19 pandemic hindered the healthcare systems worldwide and driven the market players to transform products for unexploited opportunities.
Some of the key players operating in the global injectable drug delivery market include:
• BD
• Pfizer Inc.
• Teva Pharmaceuticals Industries Ltd.
• Eli Lilly and Company
• Baxter International, Inc.
• Sandoz
• Terumo
• Schott AG
• Gerresheimer
• Ypsomed
• Bespak
• B. Braun Melsungen
• Other players
Some of the Recent Developments:
• In 2016, Biocon launched its disposable pen product in Japan, which will be distributed by its partner Fujifilm Pharma throughout the country.
• In March 2015, BD bought CareFusion Corporation to expand its capabilities and improve drug management and patient safety. In the same year, BD purchased CRISI Medical Systems, a medical technology business, in order to improve the efficiency of drug delivery via IV injectable. BD has a worldwide presence in 50 nations, allowing it to maintain its position in the global market.
• In June 2020, Pfenex Inc. announced that Alvogen, its commercialization partner, had launched Teriparatide Injection in the U.S. for a variety of indications, including postmenopausal women with osteoporosis who are at high risk of broken bones.
• In 2014, Terumo Corporation partnered with Ypsomed Group. The organization combined their prefillable polymer syringe, PLAJEX, with YpsoMate as a result of this agreement. This aided the corporation in strengthening their syringe product offerings.
• In 2015, Sanford-Burnham Medical Research Institute and Eli Lilly and Company formed a partnership to discover immunological therapeutics for inflammatory bowel disorder, lupus, and autoimmune diseases. The expertise of both institutions will be pooled to discover novel treatments for these disorders.
Segments
By Type
• Devices
o Conventional Injectables
o Pre-Filled Syringes
o Auto-Injectors
o Pen-Injectors
• Formulations
By Formulation Packaging
• Ampules
• Vials
• Cartridges
• Bottles
By Therapeutic Application
• Auto-immune diseases
• Hormonal Disorders
• Orphan Diseases
• Oncology
• Others
By Usage Pattern
• Curative Care
• Immunization
• Other
By Site of Administration
• Skin
• Circulatory/Musculoskeletal
• Organs
• Central Nervous System
By Distribution Channel
• Hospitals & Clinics
• Retail Pharmacy Stores
• Others
By Facility of Use
• Hospitals & Clinics
• Home Care Settings
• Other
By Geography
• North America
o U.S.
o Canada
o Mexico
• Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o ASEAN
• Latin America
o Brazil
o Argentina
o Colombia
• MEA
o South Africa
o Saudi Arabia
o UAE
o Egypt
Frequently Asked Questions
• What is the market size and growth projections?
• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
• What are the top performing segments, and countries / regions of each of the markets?
• What is the market size and growth rate across key countries / regions?
• How big is the global & regional market in terms of revenue and volume?
• How far market will grow in forecast period in terms of revenue and volume?
• What factors will influence demand and supply trends across each markets during the forecast period?
• What are the technology trends shaping various markets?
• Which country / region has more opportunities?
• What is the COVID-19 impact on the market and how long will it take to recover?
• Who are the key competitors of market Players?
• What are the market share (%) of Key Players?
• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?
Historic Year: 2016-2022
Forecast: 2024-2035
1 Injectable Drug Delivery Market Definition and Overview
1.1 Objectives of the Study
1.2 Overview of Injectable Drug Delivery
1.3 Injectable Drug Delivery Market Scope and Market Size Estimation
1.4 Market Segmentation
1.4.1 Types of Injectable Drug Delivery
1.4.2 Applications of Injectable Drug Delivery
1.5 Market Exchange Rate
2 Research Method and Logic
2.1 Methodology
2.2 Research Data Source
3 Market Competition Analysis
3.1 SHL Group Market Performance Analysis
3.1.1 SHL Group Basic Information
3.1.2 Product and Service Analysis
3.1.3 Strategies for Company to Deal with the Impact of COVID-19
3.1.4 SHL Group Sales, Value, Price, Gross Margin 2016-2021
3.2 Insulet Corporation Market Performance Analysis
3.2.1 Insulet Corporation Basic Information
3.2.2 Product and Service Analysis
3.2.3 Strategies for Company to Deal with the Impact of COVID-19
3.2.4 Insulet Corporation Sales, Value, Price, Gross Margin 2016-2021
3.3 Gerresheimer AG Market Performance Analysis
3.3.1 Gerresheimer AG Basic Information
3.3.2 Product and Service Analysis
3.3.3 Strategies for Company to Deal with the Impact of COVID-19
3.3.4 Gerresheimer AG Sales, Value, Price, Gross Margin 2016-2021
3.4 Elcam Medical Market Performance Analysis
3.4.1 Elcam Medical Basic Information
3.4.2 Product and Service Analysis
3.4.3 Strategies for Company to Deal with the Impact of COVID-19
3.4.4 Elcam Medical Sales, Value, Price, Gross Margin 2016-2021
3.5 BD Market Performance Analysis
3.5.1 BD Basic Information
3.5.2 Product and Service Analysis
3.5.3 Strategies for Company to Deal with the Impact of COVID-19
3.5.4 BD Sales, Value, Price, Gross Margin 2016-2021
3.6 West Pharmaceutical Services, Inc. Market Performance Analysis
3.6.1 West Pharmaceutical Services, Inc. Basic Information
3.6.2 Product and Service Analysis
3.6.3 Strategies for Company to Deal with the Impact of COVID-19
3.6.4 West Pharmaceutical Services, Inc. Sales, Value, Price, Gross Margin 2016-2021
3.7 Pfizer Inc. Market Performance Analysis
3.7.1 Pfizer Inc. Basic Information
3.7.2 Product and Service Analysis
3.7.3 Strategies for Company to Deal with the Impact of COVID-19
3.7.4 Pfizer Inc. Sales, Value, Price, Gross Margin 2016-2021
3.8 Ypsomed AG Market Performance Analysis
3.8.1 Ypsomed AG Basic Information
3.8.2 Product and Service Analysis
3.8.3 Strategies for Company to Deal with the Impact of COVID-19
3.8.4 Ypsomed AG Sales, Value, Price, Gross Margin 2016-2021
3.9 Eli Lilly and Company Market Performance Analysis
3.9.1 Eli Lilly and Company Basic Information
3.9.2 Product and Service Analysis
3.9.3 Strategies for Company to Deal with the Impact of COVID-19
3.9.4 Eli Lilly and Company Sales, Value, Price, Gross Margin 2016-2021
4 Market Segment by Type, Historical Data and Market Forecasts
4.1 Global Injectable Drug Delivery Production and Value by Type
4.1.1 Global Injectable Drug Delivery Production by Type 2016-2021
4.1.2 Global Injectable Drug Delivery Market Value by Type 2016-2021
4.2 Global Injectable Drug Delivery Market Production, Value and Growth Rate by Type 2016-2021
4.2.1 Conventional Injectable Market Production, Value and Growth Rate
4.2.2 Pre-filled Syringes Market Production, Value and Growth Rate
4.2.3 Auto-injectors Market Production, Value and Growth Rate
4.2.4 Pen-injectors Market Production, Value and Growth Rate
4.2.5 Wearables Market Production, Value and Growth Rate
4.3 Global Injectable Drug Delivery Production and Value Forecast by Type
4.3.1 Global Injectable Drug Delivery Production Forecast by Type 2021-2026
4.3.2 Global Injectable Drug Delivery Market Value Forecast by Type 2021-2026
4.4 Global Injectable Drug Delivery Market Production, Value and Growth Rate by Type Forecast 2021-2026
4.4.1 Conventional Injectable Market Production, Value and Growth Rate Forecast
4.4.2 Pre-filled Syringes Market Production, Value and Growth Rate Forecast
4.4.3 Auto-injectors Market Production, Value and Growth Rate Forecast
4.4.4 Pen-injectors Market Production, Value and Growth Rate Forecast
4.4.5 Wearables Market Production, Value and Growth Rate Forecast
5 Market Segment by Application, Historical Data and Market Forecasts
5.1 Global Injectable Drug Delivery Consumption and Value by Application
5.1.1 Global Injectable Drug Delivery Consumption by Application 2016-2021
5.1.2 Global Injectable Drug Delivery Market Value by Application 2016-2021
5.2 Global Injectable Drug Delivery Market Consumption, Value and Growth Rate by Application 2016-2021
5.2.1 Autoimmune Disorders Market Consumption, Value and Growth Rate
5.2.2 Diabetes Market Consumption, Value and Growth Rate
5.2.3 Pain Management Market Consumption, Value and Growth Rate
5.2.4 Aesthetic Treatments Market Consumption, Value and Growth Rate
5.2.5 Others Market Consumption, Value and Growth Rate
5.3 Global Injectable Drug Delivery Consumption and Value Forecast by Application
5.3.1 Global Injectable Drug Delivery Consumption Forecast by Application 2021-2026
5.3.2 Global Injectable Drug Delivery Market Value Forecast by Application 2021-2026
5.4 Global Injectable Drug Delivery Market Consumption, Value and Growth Rate by Application Forecast 2021-2026
5.4.1 Autoimmune Disorders Market Consumption, Value and Growth Rate Forecast
5.4.2 Diabetes Market Consumption, Value and Growth Rate Forecast
5.4.3 Pain Management Market Consumption, Value and Growth Rate Forecast
5.4.4 Aesthetic Treatments Market Consumption, Value and Growth Rate Forecast
5.4.5 Others Market Consumption, Value and Growth Rate Forecast
6 Global Injectable Drug Delivery by Region, Historical Data and Market Forecasts
6.1 Global Injectable Drug Delivery Sales by Region 2016-2021
6.2 Global Injectable Drug Delivery Market Value by Region 2016-2021
6.3 Global Injectable Drug Delivery Market Sales, Value and Growth Rate by Region 2016-2021
6.3.1 North America
6.3.2 Europe
6.3.3 Asia Pacific
6.3.4 South America
6.3.5 Middle East and Africa
6.4 Global Injectable Drug Delivery Sales Forecast by Region 2021-2026
6.5 Global Injectable Drug Delivery Market Value Forecast by Region 2021-2026
6.6 Global Injectable Drug Delivery Market Sales, Value and Growth Rate Forecast by Region 2021-2026
6.6.1 North America
6.6.2 Europe
6.6.3 Asia Pacific
6.6.4 South America
6.6.5 Middle East and Africa
7 United State Market Size Analysis 2016-2026
7.1 United State Injectable Drug Delivery Value and Market Growth 2016-2021
7.2 United State Injectable Drug Delivery Sales and Market Growth 2016-2021
7.3 United State Injectable Drug Delivery Market Value Forecast 2021-2026
8 Canada Market Size Analysis 2016-2026
8.1 Canada Injectable Drug Delivery Value and Market Growth 2016-2021
8.2 Canada Injectable Drug Delivery Sales and Market Growth 2016-2021
8.3 Canada Injectable Drug Delivery Market Value Forecast 2021-2026
9 Germany Market Size Analysis 2016-2026
9.1 Germany Injectable Drug Delivery Value and Market Growth 2016-2021
9.2 Germany Injectable Drug Delivery Sales and Market Growth 2016-2021
9.3 Germany Injectable Drug Delivery Market Value Forecast 2021-2026
10 UK Market Size Analysis 2016-2026
10.1 UK Injectable Drug Delivery Value and Market Growth 2016-2021
10.2 UK Injectable Drug Delivery Sales and Market Growth 2016-2021
10.3 UK Injectable Drug Delivery Market Value Forecast 2021-2026
11 France Market Size Analysis 2016-2026
11.1 France Injectable Drug Delivery Value and Market Growth 2016-2021
11.2 France Injectable Drug Delivery Sales and Market Growth 2016-2021
11.3 France Injectable Drug Delivery Market Value Forecast 2021-2026
12 Italy Market Size Analysis 2016-2026
12.1 Italy Injectable Drug Delivery Value and Market Growth 2016-2021
12.2 Italy Injectable Drug Delivery Sales and Market Growth 2016-2021
12.3 Italy Injectable Drug Delivery Market Value Forecast 2021-2026
13 Spain Market Size Analysis 2016-2026
13.1 Spain Injectable Drug Delivery Value and Market Growth 2016-2021
13.2 Spain Injectable Drug Delivery Sales and Market Growth 2016-2021
13.3 Spain Injectable Drug Delivery Market Value Forecast 2021-2026
14 Russia Market Size Analysis 2016-2026
14.1 Russia Injectable Drug Delivery Value and Market Growth 2016-2021
14.2 Russia Injectable Drug Delivery Sales and Market Growth 2016-2021
14.3 Russia Injectable Drug Delivery Market Value Forecast 2021-2026
15 China Market Size Analysis 2016-2026
15.1 China Injectable Drug Delivery Value and Market Growth 2016-2021
15.2 China Injectable Drug Delivery Sales and Market Growth 2016-2021
15.3 China Injectable Drug Delivery Market Value Forecast 2021-2026
16 Japan Market Size Analysis 2016-2026
16.1 Japan Injectable Drug Delivery Value and Market Growth 2016-2021
16.2 Japan Injectable Drug Delivery Sales and Market Growth 2016-2021
16.3 Japan Injectable Drug Delivery Market Value Forecast 2021-2026
17 South Korea Market Size Analysis 2016-2026
17.1 South Korea Injectable Drug Delivery Value and Market Growth 2016-2021
17.2 South Korea Injectable Drug Delivery Sales and Market Growth 2016-2021
17.3 South Korea Injectable Drug Delivery Market Value Forecast 2021-2026
18 Australia Market Size Analysis 2016-2026
18.1 Australia Injectable Drug Delivery Value and Market Growth 2016-2021
18.2 Australia Injectable Drug Delivery Sales and Market Growth 2016-2021
18.3 Australia Injectable Drug Delivery Market Value Forecast 2021-2026
19 Thailand Market Size Analysis 2016-2026
19.1 Thailand Injectable Drug Delivery Value and Market Growth 2016-2021
19.2 Thailand Injectable Drug Delivery Sales and Market Growth 2016-2021
19.3 Thailand Injectable Drug Delivery Market Value Forecast 2021-2026
20 Brazil Market Size Analysis 2016-2026
20.1 Brazil Injectable Drug Delivery Value and Market Growth 2016-2021
20.2 Brazil Injectable Drug Delivery Sales and Market Growth 2016-2021
20.3 Brazil Injectable Drug Delivery Market Value Forecast 2021-2026
21 Argentina Market Size Analysis 2016-2026
21.1 Argentina Injectable Drug Delivery Value and Market Growth 2016-2021
21.2 Argentina Injectable Drug Delivery Sales and Market Growth 2016-2021
21.3 Argentina Injectable Drug Delivery Market Value Forecast 2021-2026
22 Chile Market Size Analysis 2016-2026
22.1 Chile Injectable Drug Delivery Value and Market Growth 2016-2021
22.2 Chile Injectable Drug Delivery Sales and Market Growth 2016-2021
22.3 Chile Injectable Drug Delivery Market Value Forecast 2021-2026
23 South Africa Market Size Analysis 2016-2026
23.1 South Africa Injectable Drug Delivery Value and Market Growth 2016-2021
23.2 South Africa Injectable Drug Delivery Sales and Market Growth 2016-2021
23.3 South Africa Injectable Drug Delivery Market Value Forecast 2021-2026
24 Egypt Market Size Analysis 2016-2026
24.1 Egypt Injectable Drug Delivery Value and Market Growth 2016-2021
24.2 Egypt Injectable Drug Delivery Sales and Market Growth 2016-2021
24.3 Egypt Injectable Drug Delivery Market Value Forecast 2021-2026
25 UAE Market Size Analysis 2016-2026
25.1 UAE Injectable Drug Delivery Value and Market Growth 2016-2021
25.2 UAE Injectable Drug Delivery Sales and Market Growth 2016-2021
25.3 UAE Injectable Drug Delivery Market Value Forecast 2021-2026
26 Saudi Arabia Market Size Analysis 2016-2026
26.1 Saudi Arabia Injectable Drug Delivery Value and Market Growth 2016-2021
26.2 Saudi Arabia Injectable Drug Delivery Sales and Market Growth 2016-2021
26.3 Saudi Arabia Injectable Drug Delivery Market Value Forecast 2021-2026
27 Market Dynamic Analysis and Development Suggestions
27.1 Market Drivers
27.2 Market Development Constraints
27.3 PEST Analysis
27.3.1 Political Factors
27.3.2 Economic Factors
27.3.3 Social Factors
27.3.4 Technological Factors
27.4 Industry Trends Under COVID-19
27.4.1 Risk Assessment on COVID-19
27.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
27.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
27.5 Market Entry Strategy Analysis
27.5.1 Market Definition
27.5.2 Client
27.5.3 Distribution Model
27.5.4 Product Messaging and Positioning
27.5.5 Price
27.6 Advice on Entering the Market
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.
}})
Select a license type that suits your business needs
US $3950
Only Three Thousand Nine Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $4950
Only Four Thousand Nine Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $5950
Only Five Thousand Nine Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI